Richard Anderson
Stock Analyst at Wedbush
(3.58)
# 844
Out of 4,981 analysts
140
Total ratings
58.9%
Success rate
3.77%
Average return
Main Sectors:
Stocks Rated by Richard Anderson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HR Healthcare Realty Trust | Maintains: Neutral | $18 → $16 | $18.34 | -12.76% | 9 | May 5, 2025 | |
| DOC Healthpeak Properties | Maintains: Outperform | $24 → $22 | $18.08 | +21.68% | 5 | Apr 28, 2025 | |
| SAFE Safehold | Reiterates: Neutral | $20 | $16.48 | +21.36% | 5 | Apr 1, 2025 | |
| NHI National Health Investors | Reiterates: Outperform | $88 | $78.29 | +12.40% | 4 | Mar 17, 2025 | |
| CTRE CareTrust REIT | Reiterates: Underperform | $26 | $34.20 | -23.98% | 3 | Mar 14, 2025 | |
| STRW Strawberry Fields REIT | Maintains: Outperform | $12 → $14 | $11.85 | +18.14% | 2 | Mar 5, 2025 | |
| VTR Ventas | Maintains: Outperform | $69 → $78 | $69.73 | +11.86% | 7 | Feb 14, 2025 | |
| WELL Welltower | Upgrades: Outperform | $145 → $167 | $169.13 | -1.26% | 5 | Feb 14, 2025 | |
| UMH UMH Properties | Reiterates: Neutral | $20 | $15.18 | +31.75% | 4 | Jan 13, 2025 | |
| DEI Douglas Emmett | Upgrades: Outperform | $19 → $21 | $16.64 | +26.20% | 2 | Jan 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $81 → $70 | $77.18 | -9.30% | 5 | Jan 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $34 → $33 | $33.16 | -0.48% | 3 | Jan 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $72 | $58.42 | +23.25% | 1 | Dec 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $120 → $110 | $84.92 | +29.53% | 7 | Dec 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $209 | $166.95 | +25.19% | 5 | Oct 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $40 | $36.22 | +10.44% | 3 | Sep 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $118 → $131 | $109.51 | +19.62% | 4 | Aug 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $68 → $75 | $66.44 | +12.88% | 5 | Aug 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $264 → $301 | $267.09 | +12.70% | 8 | Aug 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $45 → $49 | $38.37 | +27.70% | 4 | Aug 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $44 → $45 | $36.26 | +24.10% | 3 | Aug 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $28 → $33 | $30.66 | +7.63% | 3 | Aug 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $154 → $184 | $142.20 | +29.40% | 4 | Aug 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $22 | $17.60 | +25.00% | 2 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $17 | $11.95 | +42.26% | 3 | May 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $51 | $48.05 | +6.14% | 2 | May 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $59 → $49 | $52.19 | -6.11% | 5 | Apr 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $45 | $43.36 | +3.78% | 1 | Apr 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $67 | $58.56 | +14.41% | 2 | Mar 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $11 → $7.5 | $2.94 | +155.10% | 5 | Feb 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $94 | $100.17 | -6.16% | 1 | Oct 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $14 | $11.68 | +19.86% | 2 | Oct 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $16 | $19.05 | -16.01% | 5 | Oct 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $34 | $42.48 | -19.96% | 1 | Oct 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $179 | $195.15 | -8.28% | 1 | Oct 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | n/a | $7.13 | - | 2 | May 7, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | n/a | $7.51 | - | 5 | Nov 6, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $4.54 | - | 2 | Jul 10, 2017 |
Healthcare Realty Trust
May 5, 2025
Maintains: Neutral
Price Target: $18 → $16
Current: $18.34
Upside: -12.76%
Healthpeak Properties
Apr 28, 2025
Maintains: Outperform
Price Target: $24 → $22
Current: $18.08
Upside: +21.68%
Safehold
Apr 1, 2025
Reiterates: Neutral
Price Target: $20
Current: $16.48
Upside: +21.36%
National Health Investors
Mar 17, 2025
Reiterates: Outperform
Price Target: $88
Current: $78.29
Upside: +12.40%
CareTrust REIT
Mar 14, 2025
Reiterates: Underperform
Price Target: $26
Current: $34.20
Upside: -23.98%
Strawberry Fields REIT
Mar 5, 2025
Maintains: Outperform
Price Target: $12 → $14
Current: $11.85
Upside: +18.14%
Ventas
Feb 14, 2025
Maintains: Outperform
Price Target: $69 → $78
Current: $69.73
Upside: +11.86%
Welltower
Feb 14, 2025
Upgrades: Outperform
Price Target: $145 → $167
Current: $169.13
Upside: -1.26%
UMH Properties
Jan 13, 2025
Reiterates: Neutral
Price Target: $20
Current: $15.18
Upside: +31.75%
Douglas Emmett
Jan 2, 2025
Upgrades: Outperform
Price Target: $19 → $21
Current: $16.64
Upside: +26.20%
Jan 2, 2025
Downgrades: Underperform
Price Target: $81 → $70
Current: $77.18
Upside: -9.30%
Jan 2, 2025
Upgrades: Outperform
Price Target: $34 → $33
Current: $33.16
Upside: -0.48%
Dec 17, 2024
Initiates: Neutral
Price Target: $72
Current: $58.42
Upside: +23.25%
Dec 6, 2024
Maintains: Neutral
Price Target: $120 → $110
Current: $84.92
Upside: +29.53%
Oct 25, 2024
Reiterates: Outperform
Price Target: $209
Current: $166.95
Upside: +25.19%
Sep 20, 2024
Reiterates: Outperform
Price Target: $40
Current: $36.22
Upside: +10.44%
Aug 5, 2024
Maintains: Outperform
Price Target: $118 → $131
Current: $109.51
Upside: +19.62%
Aug 5, 2024
Maintains: Neutral
Price Target: $68 → $75
Current: $66.44
Upside: +12.88%
Aug 5, 2024
Maintains: Neutral
Price Target: $264 → $301
Current: $267.09
Upside: +12.70%
Aug 5, 2024
Maintains: Outperform
Price Target: $45 → $49
Current: $38.37
Upside: +27.70%
Aug 5, 2024
Maintains: Outperform
Price Target: $44 → $45
Current: $36.26
Upside: +24.10%
Aug 5, 2024
Maintains: Outperform
Price Target: $28 → $33
Current: $30.66
Upside: +7.63%
Aug 5, 2024
Maintains: Outperform
Price Target: $154 → $184
Current: $142.20
Upside: +29.40%
May 30, 2024
Reiterates: Outperform
Price Target: $22
Current: $17.60
Upside: +25.00%
May 28, 2024
Reiterates: Neutral
Price Target: $17
Current: $11.95
Upside: +42.26%
May 17, 2024
Reiterates: Outperform
Price Target: $51
Current: $48.05
Upside: +6.14%
Apr 25, 2024
Downgrades: Neutral
Price Target: $59 → $49
Current: $52.19
Upside: -6.11%
Apr 22, 2024
Initiates: Neutral
Price Target: $45
Current: $43.36
Upside: +3.78%
Mar 28, 2024
Reiterates: Neutral
Price Target: $67
Current: $58.56
Upside: +14.41%
Feb 20, 2024
Downgrades: Neutral
Price Target: $11 → $7.5
Current: $2.94
Upside: +155.10%
Oct 3, 2023
Initiates: Outperform
Price Target: $94
Current: $100.17
Upside: -6.16%
Oct 3, 2023
Initiates: Neutral
Price Target: $14
Current: $11.68
Upside: +19.86%
Oct 3, 2023
Initiates: Outperform
Price Target: $16
Current: $19.05
Upside: -16.01%
Oct 3, 2023
Initiates: Neutral
Price Target: $34
Current: $42.48
Upside: -19.96%
Oct 3, 2023
Initiates: Neutral
Price Target: $179
Current: $195.15
Upside: -8.28%
May 7, 2018
Upgrades: Neutral
Price Target: n/a
Current: $7.13
Upside: -
Nov 6, 2017
Upgrades: Neutral
Price Target: n/a
Current: $7.51
Upside: -
Jul 10, 2017
Upgrades: Buy
Price Target: n/a
Current: $4.54
Upside: -